MedTrace Logo

CARE-HF Long Term Follow-up

NCT00318357 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 309

Last updated 2025-07-02

Study results available
· View outcomes & findings →

Summary

The CARE-HF long-term follow-up trial evaluates the effects of cardiac resynchronization (CR) therapy on the mortality of patients from the CARE-HF program for an additional 4 year follow-up. Investigators are free to choose whatever available treatment they believe is in the patient's best interest.

Conditions

Interventions

DEVICE

Continuation of CRT

Implantation of CRT device and medical treatment according normal hospital routine.

DEVICE

Upgrade to CRT

Recommended implantation of a Medtronic CRT InSync® family devices. Implantation of CRT device and medical treatment according normal hospital routine.

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • John Cleland, Professor · The University of Hull; Department of Cardiology; United Kingdom

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00318357 on ClinicalTrials.gov